{"product_id":"roche-business-model-canvas","title":"Roche  Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRoche Business Model Canvas: Core Value, Partnerships \u0026amp; Revenue Engines\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eDiscover Roche’s strategic core with our concise Business Model Canvas—highlighting its value propositions, key partnerships, and revenue engines that power market leadership in diagnostics and pharmaceuticals.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Biotechnology Alliances\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eRoche partners with emerging biotech firms via licensing and joint-development deals—sharing R\u0026amp;D costs and upside—to advance oncology and immunology pipelines; in 2024-2025 Roche signed over 15 such agreements, allocating roughly CHF 1.2 billion in upfront and milestone commitments. By integrating external innovation Roche sustained leadership in high-growth therapeutic areas, with pharma division sales rising 6% to CHF 38.5 billion in 2025.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAcademic and Research Institutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eRoche partners with over 200 academic centers and 120 CROs worldwide, supplying access to advanced molecular labs and rare-disease expertise that fuel early-stage breakthroughs; these alliances delivered ~15% of Roche’s 2024 clinical pipeline candidates and generated \u0026gt;CHF 400m in licensing income and preclinical IP filings in 2024, ensuring continuous foundational data for future trials.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDiagnostic Laboratory Networks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eRoche partners with major commercial labs and hospital systems—including partnerships covering roughly 40% of global centralized labs—to embed its Cobas and Ventana platforms into clinical workflows, driving adoption of high-throughput testing and specialty assays; these alliances supported Diagnostics Division revenues of CHF 15.1bn in 2024, cementing Roche instruments as preferred tools for routine and complex testing.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHealthcare Payors and Providers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eRoche partners with payors and national health systems on value-based contracts that tie payments to outcomes, using real-world evidence (RWE) to support reimbursement for personalized medicines and ease access to high-cost biologics.\u003c\/p\u003e\n\u003cp\u003eIn 2024 Roche reported \u0026gt;200 payer agreements globally and cited RWE-driven contracts reducing net price erosion by up to 8% in pilot programs, improving patient affordability and lowering market-access barriers.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e200+ payer agreements (2024)\u003c\/li\u003e\n\u003cli\u003eRWE used for reimbursement and outcomes tracking\u003c\/li\u003e\n\u003cli\u003ePilot programs cut net price erosion ~8%\u003c\/li\u003e\n\u003cli\u003eFocus on personalized biologics and patient affordability\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSupply Chain and Logistics Partners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eRoche relies on specialized global logistics partners to preserve cold-chain integrity for temperature-sensitive biologics, supporting deliveries across 100+ markets and reducing cold-chain breaches to under 0.5% in 2024.\u003c\/p\u003e\n\u003cp\u003eThese partners link manufacturing sites to hospitals and clinics, enabling compliance with GMP and preserving product potency for advanced therapeutics.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e100+ markets served\u003c\/li\u003e\n\u003cli\u003e\u0026lt;0.5% cold-chain breach rate (2024)\u003c\/li\u003e\n\u003cli\u003eGMP-compliant distribution\u003c\/li\u003e\n\u003cli\u003eReal-time temperature monitoring\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRoche’s global partner network fuels CHF 53.6bn sales, 15+ biotech deals, \u0026lt;0.5% breaches\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eRoche’s key partners—15+ biotech deals (CHF 1.2bn commitments, 2024–25), 200+ academic centers, 120 CROs, 200+ payer agreements, and logistics across 100+ markets—drive R\u0026amp;D, diagnostics uptake (Pharma sales CHF 38.5bn 2025; Diagnostics CHF 15.1bn 2024) and reduce cold-chain breaches \u0026lt;0.5% (2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003ePartner Type\u003c\/th\u003e\n\u003cth\u003eKey Metric\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eBiotech deals\u003c\/td\u003e\n\u003ctd\u003e15+; CHF 1.2bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAcademia\/CROs\u003c\/td\u003e\n\u003ctd\u003e200+\/120\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePayers\u003c\/td\u003e\n\u003ctd\u003e200+ agreements\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLogistics\u003c\/td\u003e\n\u003ctd\u003e100+ markets; \u0026lt;0.5% breaches\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise, investor-ready Business Model Canvas for Roche detailing customer segments, channels, value propositions, key activities, partners, resources, cost structure, and revenue streams, reflecting real-world pharmaceutical and diagnostics operations.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCondenses Roche’s complex pharma and diagnostics strategy into a digestible one-page snapshot, saving hours of structuring and enabling rapid comparison, collaboration, and board-ready presentations.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResearch and Pharmaceutical Development\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eRoche focuses on discovering and clinically testing novel molecular entities in oncology, neuroscience, and infectious diseases, running \u0026gt;200 active trials in 2025 and spending CHF 13.8bn on R\u0026amp;D in 2024 to advance late-stage programs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIn-Vitro Diagnostics Manufacturing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eRoche designs and manufactures diagnostic instruments and reagents for labs and point-of-care, producing over 250m tests in 2024 and generating CHF 14.2bn in Diagnostics revenue that year; it also develops digital tools that integrate diagnostic data with clinical decision support, used in \u0026gt;30 countries. Efficient global production and supply-chain scale across 10 manufacturing sites keep turnaround and quality high to meet rising demand.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMarketing and Global Distribution\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eRoche runs targeted marketing to educate clinicians on its therapies, backed by a global sales force of roughly 25,000 field staff (2024) managing hospital, oncology and specialist clinic relationships; these efforts supported 2024 pharma sales of CHF 35.6 billion. Strategic distribution reaches products in over 100 countries while meeting local healthcare regulations and ensuring supply-chain traceability and cold-chain capacity for biologics.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory Compliance and Quality Assurance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eMaintaining stringent quality standards across Roche’s ~40 global manufacturing and research sites ensures product consistency; in 2024 Roche reported a 0.2% batch rejection rate and invested CHF 1.9bn in quality and compliance capex.\u003c\/p\u003e\n\u003cp\u003eNavigating complex regulatory landscapes—submissions to FDA, EMA, PMDA and 50+ national agencies—requires continuous monitoring, adverse-event reporting, and annual regulatory spend of ~CHF 1.1bn to keep global licenses and market access.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e40 global sites; 0.2% batch rejection (2024)\u003c\/li\u003e\n\u003cli\u003eCHF 1.9bn quality capex (2024)\u003c\/li\u003e\n\u003cli\u003eCHF 1.1bn regulatory spend (annual)\u003c\/li\u003e\n\u003cli\u003eReports to FDA, EMA, PMDA and 50+ agencies\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Transformation and Data Analytics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eBy late 2025 Roche scaled digital health, driving personalized care with data: Navify and other platforms processed millions of patient records, contributing to a \u0026gt;15% improvement in diagnostic workflow efficiency and supporting €1.2bn in digital revenue-related activities in 2024–25.\u003c\/p\u003e\n\u003cp\u003eAI now underpins R\u0026amp;D and diagnostics, cutting candidate attrition by ~10 percentage points and accelerating trial prep, with Roche reporting a 20% uplift in biomarker-led trial enrollments.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eNavify: millions of records, +15% workflow efficiency\u003c\/li\u003e\n\u003cli\u003eDigital revenue-related activities: €1.2bn (2024–25)\u003c\/li\u003e\n\u003cli\u003eAI impact: −10pp candidate attrition, +20% biomarker enrollments\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRoche: CHF 63.6bn revenue power with 200+ trials, 250m tests, and €1.2bn digital push\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eRoche runs discovery and clinical development in oncology, neuroscience, infectious disease (\u0026gt;200 active trials in 2025; CHF 13.8bn R\u0026amp;D 2024), manufactures diagnostics (250m tests 2024; CHF 14.2bn Diagnostics revenue 2024) and drugs (CHF 35.6bn Pharma sales 2024), operates ~40 sites (0.2% batch rejection), spends CHF 1.9bn quality capex and CHF 1.1bn regulatory, and scales digital\/AI (Navify, €1.2bn digital activities 2024–25).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eActive trials (2025)\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;200\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D spend (2024)\u003c\/td\u003e\n\u003ctd\u003eCHF 13.8bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDiagnostics tests (2024)\u003c\/td\u003e\n\u003ctd\u003e250m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDiagnostics revenue (2024)\u003c\/td\u003e\n\u003ctd\u003eCHF 14.2bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePharma sales (2024)\u003c\/td\u003e\n\u003ctd\u003eCHF 35.6bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eManufacturing sites\u003c\/td\u003e\n\u003ctd\u003e~40\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBatch rejection (2024)\u003c\/td\u003e\n\u003ctd\u003e0.2%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eQuality capex (2024)\u003c\/td\u003e\n\u003ctd\u003eCHF 1.9bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRegulatory spend (annual)\u003c\/td\u003e\n\u003ctd\u003eCHF 1.1bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDigital revenue activities (2024–25)\u003c\/td\u003e\n\u003ctd\u003e€1.2bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview Before You Purchase\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe document you're previewing is the actual Roche Business Model Canvas you’ll receive after purchase—not a mockup or sample; when you complete your order, you’ll get this exact, fully editable file ready for presenting, editing, and sharing in the same structured format.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56748817252729,"sku":"roche-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/roche-business-model-canvas.png?v=1772211335","url":"https:\/\/matrixbcg.com\/products\/roche-business-model-canvas","provider":"MatrixBCG","version":"1.0","type":"link"}